We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0IGA market cap is 2.68B. The company's latest EPS is USD -14.6577 and P/E is -0.26.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.11B | 1.56B | 1.79B | 1.12B | 1.05B |
| Operating Income | 114.1M | 433.8M | 352.6M | -172.7M | -726.4M |
| Net Income | 54.5M | 305.1M | 230.9M | -223.8M | -760.5M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.33B | 2.88B | 2.96B | 3.17B | 1.82B |
| Total Liabilities | 1.24B | 1.44B | 1.34B | 1.78B | 1.17B |
| Total Equity | 1.09B | 1.45B | 1.62B | 1.38B | 649.3M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 188M | 536M | 321.1M | -34.1M | -206.3M |
| Investing | -96.9M | -151M | -225M | -381.3M | 212.3M |
| Financing | -35.9M | 69.5M | -141M | 481.2M | -535.7M |
| Market Cap | 2.68B |
| Price to Earnings Ratio | -0.26 |
| Price to Sales Ratio | 0.19 |
| Price to Cash Ratio | 1.8 |
| Price to Book Ratio | 0.31 |
| Dividend Yield | - |
| Shares Outstanding | 51.88M |
| Average Volume (1 week) | 108.97k |
| Average Volume (1 Month) | 29.73k |
| 52 Week Change | 0.00% |
| 52 Week High | 51.60 |
| 52 Week Low | 51.60 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Emergent Biosolutions Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.emergentbiosolutions.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
